Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Emerg Microbes Infect ; 11(1): 136-146, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34890523

RESUMO

Candida auris has globally emerged as a multidrug-resistant fungus linked to healthcare-associated outbreaks. There is still limited evidence on its virulence, pathogenicity determinants, and complex host-pathogen interactions. This study analyzes the in vivo fungal behaviour, immune response, and host-pathogen interactions upon C. auris infection compared to C. albicans and C. parapsilosis in G. mellonella. This was performed by immunolabelling fungal structures and larval plasmatocytes and using a quantitative approach incorporating bioinformatic morphometric techniques into the study of microbial pathogenesis. C. auris presents a remarkably higher immunogenic activity than expected at its moderate degree of tissue invasion. It induces a greater inflammatory response than C. albicans and C. parapsilosis at the expense of plasmatocyte nodule formation, especially in non-aggregative strains. It specifically invades the larval respiratory system, in a pattern not previously observed in other Candida species, and presents inter-phenotypic tissue tropism differences. C. auris filaments in vivo less frequently than C. albicans or C. parapsilosis mostly through pseudohyphal growth. Filamentation might not be a major pathogenic determinant in C. auris, as less virulent aggregative phenotypes form pseudohyphae to a greater extent. C. auris has important both interspecific and intraspecific virulence and phenotype heterogeneity, with aggregative phenotypes of C. auris sharing characteristics with low pathogenic species such as C. parapsilosis. Our work suggests that C. auris owns an important morphogenetic plasticity that distinguishes it from other yeasts of the genus. Routine phenotypic identification of aggregative or non-aggregative phenotypes should be performed in the clinical setting as it may impact patient management.


Assuntos
Candida auris/fisiologia , Interações Hospedeiro-Patógeno , Mariposas/imunologia , Mariposas/microbiologia , Animais , Candida albicans/imunologia , Candida albicans/patogenicidade , Candida albicans/fisiologia , Candida auris/citologia , Candida auris/imunologia , Candida auris/patogenicidade , Candida parapsilosis/imunologia , Candida parapsilosis/patogenicidade , Candida parapsilosis/fisiologia , Hemócitos/imunologia , Hemócitos/fisiologia , Hemolinfa/microbiologia , Imunidade , Larva/microbiologia , Mariposas/fisiologia , Sistema Respiratório/imunologia , Sistema Respiratório/microbiologia , Virulência
2.
Nat Commun ; 12(1): 7197, 2021 12 10.
Artigo em Inglês | MEDLINE | ID: mdl-34893621

RESUMO

Candida auris is an emerging healthcare-associated pathogen of global concern. Recent reports have identified C. auris isolates that grow in cellular aggregates or filaments, often without a clear genetic explanation. To investigate the regulation of C. auris morphogenesis, we applied an Agrobacterium-mediated transformation system to all four C. auris clades. We identified aggregating mutants associated with disruption of chitin regulation, while disruption of ELM1 produced a polarized, filamentous growth morphology. We developed a transiently expressed Cas9 and sgRNA system for C. auris that significantly increased targeted transformation efficiency across the four C. auris clades. Using this system, we confirmed the roles of C. auris morphogenesis regulators. Morphogenic mutants showed dysregulated chitinase expression, attenuated virulence, and altered antifungal susceptibility. Our findings provide insights into the genetic regulation of aggregating and filamentous morphogenesis in C. auris. Furthermore, the genetic tools described here will allow for efficient manipulation of the C. auris genome.


Assuntos
Candida auris/citologia , Candida auris/genética , Candida auris/fisiologia , Proteínas Fúngicas/genética , Morfogênese/genética , Genética Reversa , Animais , Antifúngicos/farmacologia , Sistemas CRISPR-Cas , Candida auris/efeitos dos fármacos , Candidíase/microbiologia , Modelos Animais de Doenças , Farmacorresistência Fúngica/efeitos dos fármacos , Fluconazol , Regulação Fúngica da Expressão Gênica , Morfogênese/efeitos dos fármacos , Mariposas , Mutação , Proteínas Quinases/genética , Virulência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...